HPV infection screening using surface plasmon resonance in women from Kunming (Southwest China)
- PMID: 31509732
- PMCID: PMC7029204
- DOI: 10.17305/bjbms.2019.4352
HPV infection screening using surface plasmon resonance in women from Kunming (Southwest China)
Abstract
No study examined the frequency of human papillomavirus (HPV) genotypes by surface plasmon resonance (SPR) in Southwest China. This was a cross-sectional survey (The Second Affiliated Hospital of Kunming Medical University, 10/2010 to 12/2011) in 150 patients who were hospitalized or volunteered for cervical cancer (CC) screening. A HPV typing kit was used to detect 24 types of HPV by the SPR technique. The HPV-positive rate was 34.8% in women with normal cytology and 92.9% in women with CC. The frequency of HPV16 increased from 9.4% for women with normal cytology to 28.9% for cervical intraepithelial neoplasia (CIN)1, 41.4% for CIN2, 54.1% for CIN3, and 71.4% for CC (p < 0.001). The frequency of HPV18 increased from 0% for women with normal cytology to 2.6% for CIN1, 3.4% for CIN2, 5.4% for CIN3, and 21.4% for CC (p = 0.03). HPV40 was only found in one patient with CC (p = 0.04). There was no relation between HPV genotype and women's age. In Kunming (Southwest China), the frequency of HPV infection was 74.0% among women who underwent CC screening. HPV16 and HPV18 were the two most frequent genotypes. SPR could be of value for the screening of HPV infection.
Conflict of interest statement
Conflict of interest statement: The authors declare no conflict of interests
Similar articles
-
The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.PLoS One. 2020 Jun 11;15(6):e0234518. doi: 10.1371/journal.pone.0234518. eCollection 2020. PLoS One. 2020. PMID: 32525936 Free PMC article.
-
Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.Int J Cancer. 2019 Jan 1;144(1):34-42. doi: 10.1002/ijc.31633. Epub 2018 Oct 26. Int J Cancer. 2019. PMID: 29943809
-
[Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].Zhonghua Liu Xing Bing Xue Za Zhi. 2007 Oct;28(10):964-7. Zhonghua Liu Xing Bing Xue Za Zhi. 2007. PMID: 18399140 Chinese.
-
Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.Int J Cancer. 2018 Aug 15;143(4):813-822. doi: 10.1002/ijc.31368. Epub 2018 Mar 30. Int J Cancer. 2018. PMID: 29524206
-
Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.Oncotarget. 2016 Dec 13;7(50):83775-83783. doi: 10.18632/oncotarget.11959. Oncotarget. 2016. PMID: 27626178 Free PMC article.
References
-
- zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology. 2009;384(2):260–5. https://doi.org/10.1016/j.virol.2008.11.046. - PubMed
-
- Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338(7):423–8. https://doi.org/10.1097/00128360-199810000-00020. - PubMed
-
- International Human Papillomavirus Reference Center Human Papillomavirus Reference Clones. Stockholm, SE: International Human Papillomavirus Reference Center; 2018. [[Last accessed on 2018 Sep 06]]. Available from: http://www.hpvcenter.se/html/refclones.html.2018 .
-
- de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324(1):17–27. https://doi.org/10.1016/j.virol.2004.03.033. - PubMed
-
- Kjaer SK, van den Brule AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women:Population based prospective follow up study. BMJ. 2002;325(7364):572. https://doi.org/10.1136/bmj.325.7364.572. - PMC - PubMed